Total Payments
$11,560
2024 Payments
$734.87
Companies
38
Transactions
211
Medicare Patients
18,481
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$9,001 (77.9%)
Travel$1,809 (15.6%)
Consulting$700.00 (6.1%)
Education$49.77 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,001 | 201 | 77.9% |
| Travel and Lodging | $1,809 | 7 | 15.6% |
| Consulting Fee | $700.00 | 1 | 6.1% |
| Education | $49.77 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,768 | 20 | $0 (2021) |
| Medtronic Vascular, Inc. | $1,409 | 15 | $0 (2019) |
| ABIOMED | $1,369 | 13 | $0 (2023) |
| Amgen Inc. | $731.38 | 17 | $0 (2021) |
| Janssen Research & Development, LLC | $664.58 | 8 | $0 (2023) |
| Boston Scientific Corporation | $592.08 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $438.00 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $401.18 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $382.07 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $246.53 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $734.87 | 24 | Boston Scientific Corporation ($203.49) |
| 2023 | $1,260 | 36 | Janssen Research & Development, LLC ($664.58) |
| 2022 | $477.18 | 17 | ABIOMED ($128.57) |
| 2021 | $1,392 | 17 | ABIOMED ($469.83) |
| 2020 | $1,056 | 10 | Abbott Laboratories ($700.00) |
| 2019 | $2,210 | 34 | Medtronic Vascular, Inc. ($1,149) |
| 2018 | $2,983 | 34 | Abbott Laboratories ($1,305) |
| 2017 | $1,448 | 39 | Abbott Laboratories ($252.18) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.48 | General |
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $58.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/11/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.99 | General |
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.86 | General |
| 08/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/29/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $125.37 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Not Applicable | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Cardiovascular | ||||||
| 04/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $131.25 | General |
| Category: Stents | ||||||
| 01/23/2024 | Silk Road Medical, Inc. | ENROUTE Transcarotid Neuroprotection System (Device), ENROUTE Transcarotid Stent, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: Cardiovascular | ||||||
| 12/19/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 4,355 | 5,602 | $920,604 | $338,731 |
| 2022 | 53 | 4,744 | 8,337 | $1.3M | $494,000 |
| 2021 | 64 | 4,845 | 9,574 | $1.5M | $592,781 |
| 2020 | 57 | 4,537 | 8,550 | $1.3M | $495,979 |
Total Patients
18,481
Total Services
32,063
Medicare Billing
$1.9M
Procedure Codes
245
All Medicare Procedures & Services
245 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 783 | 944 | $204,328 | $84,810 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 207 | 213 | $88,395 | $29,046 | 32.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 171 | 172 | $69,167 | $23,788 | 34.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 133 | $55,062 | $19,404 | 35.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 338 | 342 | $50,958 | $17,466 | 34.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 118 | 177 | $37,701 | $16,601 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 218 | 228 | $33,516 | $14,443 | 43.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 82 | 83 | $42,394 | $14,380 | 33.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 97 | 99 | $38,193 | $14,050 | 36.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 915 | 1,094 | $37,196 | $11,033 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $24,856 | $9,247 | 37.2% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 48 | 48 | $26,976 | $9,148 | 33.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 67 | 67 | $25,594 | $8,605 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 85 | 123 | $18,327 | $7,637 | 41.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 18 | 18 | $17,316 | $5,972 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 37 | $10,841 | $5,063 | 46.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 54 | 83 | $9,711 | $4,758 | 49.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 62 | 183 | $11,529 | $3,685 | 32.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 18 | 36 | $8,496 | $3,178 | 37.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 20 | 106 | $7,420 | $2,843 | 38.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 42 | 42 | $6,468 | $2,757 | 42.6% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 27 | 28 | $7,560 | $2,736 | 36.2% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 22 | 22 | $7,392 | $2,525 | 34.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 17 | 68 | $7,684 | $2,366 | 30.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 24 | 24 | $5,736 | $2,182 | 38.0% |
About Dr. Jay Koons, MD
Dr. Jay Koons, MD is a Cardiovascular Disease healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942237714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Koons, MD has received a total of $11,560 in payments from pharmaceutical and medical device companies, with $734.87 received in 2024. These payments were reported across 211 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,001).
As a Medicare-enrolled provider, Koons has provided services to 18,481 Medicare beneficiaries, totaling 32,063 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 245 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Gainesville, FL
- Active Since 06/27/2006
- Last Updated 04/25/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1942237714
Products in Payments
- Impella (Device) $1,369
- Resolute (Device) $1,253
- Optis Coronary Imaging System (Device) $901.50
- Asahi Fielder coronary guide wire (Device) $875.03
- Omnilink Elite vascular stent system (Device) $700.00
- Repatha (Biological) $605.40
- JARDIANCE (Drug) $438.00
- XARELTO (Drug) $382.07
- ENTRESTO (Drug) $362.67
- WATCHMAN FLX (Device) $203.49
- PRALUENT (Drug) $193.72
- ELIQUIS (Drug) $189.27
- Reveal LINQ (Device) $156.27
- VERQUVO (Drug) $155.64
- Cook Medical Zilver PTX (Device) $155.22
- Vascular Lithotripsy (Device) $148.97
- Rotarex (Device) $140.79
- PRALUENT ALIROCUMAB INJECTION (Biological) $138.75
- ONYX FRONTIER (Device) $131.25
- KENGREAL (Drug) $130.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Gainesville
Dr. Juan Aranda, Md, MD
Cardiovascular Disease — Payments: $357,500
Cardiovascular Disease $357,500
Mudassar Ahmed, Mbbs, MBBS
Cardiovascular Disease — Payments: $337,874
Cardiovascular Disease $337,874
Dr. Matheen Khuddus, M.d, M.D
Cardiovascular Disease — Payments: $223,657
Cardiovascular Disease $223,657
Dr. Ann Tong, Md, MD
Cardiovascular Disease — Payments: $198,583
Cardiovascular Disease $198,583
Dr. Carl Pepine, Md, MD
Cardiovascular Disease — Payments: $195,635
Cardiovascular Disease $195,635
Dr. Michael Koren, M.d, M.D
Cardiovascular Disease — Payments: $193,105
Cardiovascular Disease $193,105